Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO BIO.B · Entity 2247 | EVP, GBL Commercial Operations | March 14, 2025 | March 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date March 14, 2025 · Filed March 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 8,171 |
Ending reported balance
After 2025-03-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-14 · Exercise / conversion · Acquired 3,000 · Balance 11,171 Row 2 · 2025-03-14 · Sale · Disposed 3,000 · Balance 8,171 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.0239 to $249.1550, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $159.32 · Expires 2026-09-07 | Direct | 0 |
Reported balance
After 2025-03-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-14 · Exercise / conversion · Disposed 3,000 · Balance 0 F2: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.0239 to $249.1550, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2025 Filed Mar 18, 2025 20:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $159.32 | $0.00 |
DisclosureSEC source: 0001062993-25-005730 · form4.xml · derivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires 2026-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | SaleBio-Rad A Common Stock | 3,000 | $247.06 | $741,184.20 |
DisclosureSEC source: 0001062993-25-005730 · form4.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,171 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.0239 to $249.1550, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 3,000 | $159.32 | $477,960.00 |
DisclosureSEC source: 0001062993-25-005730 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:57 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,456 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016378 · form4.xml · derivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,456 Underlying: Bio-Rad A Common Stock · 3,456 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 15 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 283 | $334.31 | $94,609.73 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 10 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,171 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 9 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 434 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 14 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 155 | $337.32 | $52,284.60 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 8 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,897 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 405 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 13 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406 Underlying: Bio-Rad A Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 520 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 12 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,042 Underlying: Bio-Rad A Common Stock · 520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 751 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 11 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,254 Underlying: Bio-Rad A Common Stock · 751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 3,005 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 3,005 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 145 | $337.32 | $48,911.40 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 6 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,618 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 218 | $337.32 | $73,535.76 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 4 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,358 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 268 | $337.32 | $90,401.76 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,056 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 13:36 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 17:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 369 | $281.91 | $104,023.46 |
DisclosureSEC source: 0001062993-24-012628 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,573 Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 16:22 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,535 | $0.00 Strike: $343.76 | $0.00 |
DisclosureSEC source: 0001062993-24-006215 · form4.xml · derivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,535 Underlying: Bio-Rad A Common Stock · 3,535 shares Expires 2034-03-08 F1 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 23:38 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $215.98 | $0.00 |
DisclosureSEC source: 0001062993-24-004835 · form4.xml · derivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires 2027-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 23:38 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 3,000 | $336.00 | $1,008,000.00 |
DisclosureSEC source: 0001062993-24-004835 · form4.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,942 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.53 to $336.20, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 23:38 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 3,000 | $215.98 | $647,940.00 |
DisclosureSEC source: 0001062993-24-004835 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2023 Filed Nov 28, 2023 22:48 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 642 | $305.10 | $195,874.20 |
DisclosureSEC source: 0001062993-23-021535 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,942 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.05 to $305.13, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 16 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 298 | $394.60 | $117,590.80 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 10 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,584 Read SEC document |
| September 04, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 9 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 15 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 557 Underlying: Bio-Rad A Common Stock · 557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 202 | $394.60 | $79,709.20 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 8 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,282 Read SEC document |
| September 03, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 14 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434 Underlying: Bio-Rad A Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 150 | $394.60 | $59,190.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 6 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,927 Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 405 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 13 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 811 Underlying: Bio-Rad A Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 520 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 12 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,562 Underlying: Bio-Rad A Common Stock · 520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · derivative · entry 11 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,005 Underlying: Bio-Rad A Common Stock · 3,005 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 141 | $394.60 | $55,638.60 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 4 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,644 Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 180 | $394.60 | $71,028.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 2 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,380 Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017646 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 18:02 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 500 | $379.39 | $189,695.00 |
DisclosureSEC source: 0001062993-23-013732 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,040 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 12 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 8 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 11 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 6 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,238 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 10 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114 Underlying: Bio-Rad A Common Stock · 557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 241 | $478.32 | $115,275.12 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 4 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,936 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.